A systematic literature review of prognostic factors in patients with HR+/HER2 − advanced breast cancer in Japan

ConclusionsDisease-free interval, the number of metastatic organs and liver metastasis were identified as independent prognostic factors for overall survival. These findings may help clinical decision-making to improve outcomes in patients with HR+/HER2 − advanced and metastatic breast cancer.
Source: Japanese Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research